Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS EXPLAINER

First cell therapy for solid tumours heads to the clinic: what it means for cancer treatment

Therapy built on tumour-infiltrating lymphocytes is now being prepared for at least 20 people in the United States with advanced melanoma.
  1. Sara Reardon

    1. Sara Reardon is a freelance journalist based in Bozeman, Montana.

    View author publications

    You can also search for this author in PubMed  Google Scholar

More than 35 years after it was invented, a therapy that uses immune cells extracted from a person’s own tumour is finally hitting the clinic. At least 20 people with advanced melanoma have embarked on treatment with what are called tumour-infiltrating lymphocytes (TILs), which target and kill cancer cells.

Access options

Access through your institution

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

doi: https://doi.org/10.1038/d41586-024-00673-w

References

  1. Rosenberg, S. A. et al. N. Engl. J. Med. 319, 1676–1680 (1988).

    Article  PubMed  Google Scholar 

  2. Chesney, J. et al. J. Immunother. Cancer 10, e005755 (2022).

    Article  PubMed  Google Scholar 

  3. Rohaan, M. W. et al. N. Engl. J. Med. 387, 2113–2125 (2022).

    Article  PubMed  Google Scholar 

  4. Guo, J. et al. J. Immunother. Cancer 10, e003887 (2022).

    Article  PubMed  Google Scholar 

  5. Creelan, B. C. et al. Nature Med. 27, 1410–1418 (2021).

    Article  PubMed  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing